Legend Biotech Corporation
LEGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,974,987 | $5,297,448 | $3,969,687 | $3,282,548 |
| - Cash | $286,749 | $1,277,713 | $786,031 | $688,938 |
| + Debt | $350,603 | $328,672 | $284,534 | $122,966 |
| Enterprise Value | $3,038,841 | $4,348,407 | $3,468,190 | $2,716,576 |
| Revenue | $627,241 | $285,143 | $117,005 | $68,826 |
| % Growth | 120% | 143.7% | 70% | – |
| Gross Profit | $392,660 | $140,929 | $51,642 | $68,826 |
| % Margin | 62.6% | 49.4% | 44.1% | 100% |
| EBITDA | -$113,159 | -$477,873 | -$416,536 | -$392,379 |
| % Margin | -18% | -167.6% | -356% | -570.1% |
| Net Income | -$177,026 | -$518,254 | -$446,349 | -$403,582 |
| % Margin | -28.2% | -181.8% | -381.5% | -586.4% |
| EPS Diluted | -1.94 | -5.88 | -5.62 | -5.48 |
| % Growth | 67% | -4.6% | -2.6% | – |
| Operating Cash Flow | -$144,033 | -$393,276 | -$201,281 | -$198,465 |
| Capital Expenditures | -$14,105 | -$22,722 | -$22,275 | -$45,404 |
| Free Cash Flow | -$158,138 | -$415,998 | -$223,556 | -$243,869 |